Sanara MedTech Inc. logo

SMTI

Sanara MedTech Inc. · NASDAQ

Website
Market cap
$300.6M

Sanara MedTech Inc. (SMTI) is an Industrial Specialties company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for SMTI, including 4 SEC filings and 1 earnings update. The most recent was published Nov 12, 2026.

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. It also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers; and PULSAR II Advanced Wound Irrigation System, a portable and no touch hydro-mechanical debridement system that removes bacteria and necrotic tissue without disrupting healthy tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Financial highlights

Full financials
Revenue, TTM
$111.91M
Revenue growth
+9.8%
Net income, TTM
-$3.02M
Net margin
-2.7%
Free cash flow, TTM
$7.29M
Cash
$16.79M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

News · 26 weeks39+67%
2026-05-24: 02026-05-31: 92026-06-07: 12026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 02026-07-12: 02026-07-19: 02026-07-26: 122026-08-02: 02026-08-09: 62026-08-16: 12026-08-23: 02026-08-30: 12026-09-06: 02026-09-13: 12026-09-20: 02026-09-27: 12026-10-04: 02026-10-11: 22026-10-18: 02026-10-25: 12026-11-01: 02026-11-08: 42026-11-15: 0
2026-05-242026-11-15
Mix1190d
  • SEC Filings9(82%)
  • Insider1(9%)
  • Earnings1(9%)
Activity · 52 weeks7333 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

SMTI FAQ

10 questions
  • What does Sanara MedTech Inc. do?
    Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical Activated Collagen Adjuvant powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes...
  • What is the latest news on SMTI?
    In the last 30 days Quantisnow tracked 5 wire items for SMTI: 4 SEC filings and 1 earnings update. The most recent was published on November 12, 2026.
  • What is SMTI revenue?
    Sanara MedTech Inc. (SMTI) reported $111.91M of revenue for the twelve months ended Sep 30, 2026. That is up 9.8% from the year before. Revenue for fiscal 2025 was $103.12M.
  • Is SMTI profitable?
    No. Sanara MedTech Inc. reported a net loss of $3.02M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does SMTI have?
    Sanara MedTech Inc. reported $16.79M in cash and cash equivalents and $46.72M of debt on its most recent balance sheet in SEC filings.
  • Where does SMTI stock trade?
    Sanara MedTech Inc. (SMTI) is listed on NASDAQ.
  • What sector and industry is SMTI in?
    Sanara MedTech Inc. operates in the Health Care sector, Industrial Specialties industry.
  • What are analysts saying about SMTI?
    Across the last 6 analyst actions on Sanara MedTech Inc., there were 0 upgrades and 1 downgrade. The most recent action was from H.C. Wainwright: Neutral with a $35.00 price target on 2026-07-30. Recent price targets range from $32.00 to $51.00.
  • What companies are similar to SMTI?
    Notable peers in the same industry include ZBH (Zimmer Biomet Holdings Inc.), STE (STERIS plc (Ireland)), ALGN (Align Technology Inc.), EW (Edwards Lifesciences Corporation), ISRG (Intuitive Surgical Inc.). Compare SMTI side-by-side with any of them on Quantisnow.
  • How can I track SMTI on Quantisnow?
    Quantisnow aggregates Sanara MedTech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SMTI to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change